Greg Russotti
Technology Chief & Manufacturing Officer Century Therapeutics
Seminars
Wednesday 16th September 2026
Streamlining Manufacturing Strategies for Complex Allogeneic T-Cell Therapies
2:05 pm
- Incorporating complex allogeneic edits as cell line development to reduce additional editing cycles
- Refining scale up readiness to accelerate timelines while protecting product quality and regulatory compliance
- Aligning with regulators on GMP editing component guidelines
Thursday 17th September 2026
Panel Discussion: Designing Early Manufacturing Processes with Long-term Strategic Alignment to Ensure Success in Phase 1 & Beyond
2:35 pm
- Establishing strategic manufacturing processes early to ensure phase one clarity, reduced rework and a scalable foundation for future growth
- Identifying optimal opportunities to optimize processes to improve manufacturing and trial outcomes
- Collaborating with flexible manufacturing partners to embed long term strategy from the beginning to support seamless scale up
